Worldwide plastic surgery statistics released by the International Society of Aesthetic Plastic Surgery (ISAPS) revealed that more non-surgical procedures were performed in the world than surgical procedures in 2009. This reflects “both advances in cosmetic surgery innovation and the desirability of less expensive treatments,” according to ISAPS.
The statistics—the first reliable international plastic surgery data ever gathered—found that Botulinum injection (Botox, Dysport) was the top non-surgical procedure, performed over 2.8 million times in 2009. Liposuction was the top surgical procedure, performed over 1.6 million times.
The top five non-surgical procedures were rounded out by hyaluronic acid injections (20.1% of non-surgical procedures); laser hair removal (13.1%); autologous fat injections (5.9%); and IPL laser Treatment (4.4%).
For surgical procedures, liposuction was followed by breast augmentation (17%); eyelid lift (13.5%); rhinoplasty (9.4%); and tummy tuck (7.3%).
However, the top procedures do vary among countries. “It is not always liposuction and breast augmentation that are No. 1,” says Foad Nahai, MD, ISAPS President and a plastic surgeon in Atlanta. For example, injectables are not yet as popular in other countries as they are in the U.S., he says.
The United States was the country with the most procedures performed in 2009. The top five countries were:
- United States (17.5% of total procedures)
- Brazil (14.3%)
- China (12.7%)
- India (5.2%)
- Mexico (4.8%)
“It is no surprise to me that the United States has the largest number of aesthetic procedures, and same with Brazil,” says Dr. Nahai. “But countries like China and India with emerging economies are generating a lot wealth and as that wealth is passed around, people are choosing to their spend discretionary income on aesthetic procedures.”
For more information on the plastic surgery statistics, visit the ISAPS website.
Tags: plastic surgery statistics
This entry was posted on Monday, August 16th, 2010 at 8:05 pm and is filed under In The News. You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.
